Treatment plans optimization for contrast-enhanced synchrotron stereotactic radiotherapy.
暂无分享,去创建一个
D Broggio | Y Prezado | H Elleaume | F. Estève | H. Elleaume | D. Broggio | M Edouard | F Estève | J F Adam | Y. Prezado | J. Adam | M. Edouard
[1] A Norman,et al. The CT scanner as a therapy machine. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] Jacques Balosso,et al. Enhanced Survival and Cure of F98 Glioma–Bearing Rats following Intracerebral Delivery of Carboplatin in Combination with Photon Irradiation , 2007, Clinical Cancer Research.
[3] F. Estève,et al. Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment. , 2008, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[4] I. Troprès,et al. Polymer gel dosimetry for synchrotron stereotactic radiotherapy and iodine dose-enhancement measurements , 2007, Physics in medicine and biology.
[5] S. Arcangeli,et al. DVHs evaluation in brain metastases stereotactic radiotherapy treatment plans. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] J. Le Bas,et al. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. , 2006, International journal of radiation oncology, biology, physics.
[7] M. Goitein,et al. Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.
[8] V. Bond,et al. Photon activation therapy. , 1984, Strahlentherapie.
[9] T Solberg,et al. First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx). , 1999, International journal of radiation oncology, biology, physics.
[10] T. Solberg,et al. X-ray phototherapy for canine brain masses. , 1997, Radiation oncology investigations.
[11] F Verhaegen,et al. Monte Carlo modelling of radiotherapy kV x-ray units. , 1999, Physics in medicine and biology.
[12] R. Higashida,et al. Radiation dose enhancement therapy with iodine in rabbit VX-2 brain tumors. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] Frank Verhaegen,et al. Dosimetric and microdosimetric study of contrast-enhanced radiotherapy with kilovolt x-rays , 2005, Physics in medicine and biology.
[14] B. Jones,et al. Treatment planning for a synchrotron-based radiotherapy modality. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[15] Santosh Kesari,et al. Malignant gliomas in adults. , 2008, The New England journal of medicine.
[16] B. Gouget,et al. Intracerebral delivery of 5-iodo-2'-deoxyuridine in combination with synchrotron stereotactic radiation for the therapy of the F98 glioma. , 2009, Journal of synchrotron radiation.
[17] F. Adams,et al. Absorbed dose in the presence of contrast agents during pediatric cardiac catheterization. , 1979, Medical physics.
[18] Jacques Balosso,et al. Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: first trial on rats bearing F98 gliomas. , 2003, International journal of radiation oncology, biology, physics.
[19] K. Iwamoto,et al. Diagnosis and treatment of spontaneous canine brain tumors with a CT scanner. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[20] Manuel Bardiès,et al. OEDIPE: a personalized dosimetric tool associating voxel-based models with MCNPX. , 2005, Cancer biotherapy & radiopharmaceuticals.
[21] A Bravin,et al. The radiotherapy clinical trials projects at the ESRF: technical aspects. , 2008, European journal of radiology.
[22] J Winter,et al. Radiation dose enhancement in tumors with iodine. , 1983, Medical physics.
[23] W. S. Snyder,et al. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] J. Le Bas,et al. In Vivo Measurement of Gadolinium Concentration in a Rat Glioma Model by Monochromatic Quantitative Computed Tomography: Comparison Between Gadopentetate Dimeglumine and Gadobutrol , 2004, Investigative radiology.
[25] J. Robar,et al. Tumour dose enhancement using modified megavoltage photon beams and contrast media. , 2002, Physics in medicine and biology.
[26] O. Harling,et al. Head phantoms for neutron capture therapy. , 1995, Medical physics.
[27] Olivier Tillement,et al. Gold nanoparticles designed for combining dual modality imaging and radiotherapy , 2008 .
[28] T. Solberg,et al. Calculation of radiation dose enhancement factors for dose enhancement therapy of brain tumours. , 1992, Physics in medicine and biology.
[29] F. Estève,et al. Monte Carlo dosimetry for synchrotron stereotactic radiotherapy of brain tumours , 2005, Physics in medicine and biology.
[30] James A. Scott. Photon, Electron, Proton and Neutron Interaction Data for Body Tissues ICRU Report 46. International Commission on Radiation Units and Measurements, Bethesda, 1992, $40.00 , 1993 .
[31] W E Bolch,et al. A revised dosimetric model of the adult head and brain. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] T D Solberg,et al. Dose distributions using kilovoltage x-rays and dose enhancement from iodine contrast agents. , 1999, Physics in medicine and biology.
[33] John S. Hendricks,et al. The MCNPX Monte Carlo Radiation Transport Code , 2007 .
[34] Francis Vocanson,et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. , 2008, Journal of the American Chemical Society.
[35] Marie-Claude Biston,et al. Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood-brain barrier disruption: quantitative iodine biodistribution studies and associated dosimetry. , 2005, International journal of radiation oncology, biology, physics.
[36] A Bravin,et al. Biological equivalent dose studies for dose escalation in the stereotactic synchrotron radiation therapy clinical trials. , 2009, Medical physics.
[37] Mark R Gilbert,et al. Chemoradiotherapy in malignant glioma: standard of care and future directions. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] Jacques Balosso,et al. Cure of Fisher Rats Bearing Radioresistant F98 Glioma Treated with cis-Platinum and Irradiated with Monochromatic Synchrotron X-Rays , 2004, Cancer Research.
[39] J. Hainfeld,et al. Radiotherapy enhancement with gold nanoparticles , 2008, The Journal of pharmacy and pharmacology.
[40] M Bardiès,et al. Validation of a personalized dosimetric evaluation tool (Oedipe) for targeted radiotherapy based on the Monte Carlo MCNPX code , 2006, Physics in medicine and biology.
[41] J Balosso,et al. Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds , 2004, British Journal of Cancer.
[42] E. Bruera,et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.